The Bart Barlogie Clinical Investigator Award

In recognition to the outstanding research developed by Dr. Bart Barlogie in the field of multiple myeloma, the IMS Board of Directors established the Bart Barlogie Clinical Investigator Award. This award is aimed at formally recognizing and stimulating excellence in myeloma research.

The Bart Barlogie Clinical Investigator Award will be given to an investigator in recognition of their research in the myeloma field.

 

Recipient Profile

Sonja Zweegman, MD, PhD, is head of the Department of Hematology and vice chair of the Cancer Center Amsterdam, Amsterdam UMC in Amsterdam, the Netherlands. She is chairman of the Dutch HOVON Myeloma Working Group.

Her clinical research is focused the optimization of treatment strategies for patients with Multiple Myeloma, with a particular focus on personalized care for older and frail patients. She is principal investigator of multiple national and international clinical trials evaluating frailty-adapted treatment approaches and investigating the predictive value of geriatric assessments and biological frailty markers for treatment feasibility and outcomes.

Furthermore, she co-leads the Multiple Myeloma translational research group within the Department of Hematology, driving the integration of cutting-edge translational science with clinical care to advance next-generation immunotherapeutic strategies for Multiple Myeloma. Research activities are centred on unravelling the mechanisms underlying response and resistance to immune therapies and on pioneering innovative therapeutic approaches, including the development of next-generation CAR-T cell therapies with subsequent translation into investigator-initiated Phase I clinical trials. Within the International Myeloma Working Group she co-chairs the Quality-of-Life working group, where she leads international efforts to incorporate patient-reported outcomes into research and clinical practice. She is author and co-author of more than 350 peer-reviewed publications and multiple book chapters.

Past Recipients

  • 2015 – B. Paiva
  • 2017– G. Palladini
  • 2019 – F. Gay
  • 2021 – S. Usmani
  • 2022 – MV Mateos
  • 2023 – S. Kumar
  • 2024 – S. Lonial
  • 2025 – E. Zamagni
  • 2026 – S. Zweegman

Why Become a Member

The International Myeloma Society is a professional, scientific, and medical society established to bring together clinical and experimental scientists involved in the study of myeloma. The purpose of this society is to promote research, education, clinical studies (including diagnosis and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide.

The IMS is a membership organization comprised of basic research scientists, and clinical investigators in the field along with physicians and other healthcare practitioners.

Login
See All of the Member Benefits
Become a Member Today

Stay updated on our Events

  • This field is for validation purposes and should be left unchanged.